A condition affecting an estimated one in eight women of reproductive age worldwide—and around 4.5 million women in the Philippines—has been given a new name to better reflect its broader impact on women’s health.
Previously known as Polycystic Ovary Syndrome (PCOS), the condition is now being referred to by the global health community as Polyendocrine Metabolic Ovarian Syndrome (PMOS). The proposed name highlights that the disorder extends far beyond the ovaries, involving hormonal imbalances, metabolic health, weight management, and long-term disease risks.
Healthcare experts say the former name often created the misconception that the condition was primarily about ovarian cysts, even though many women diagnosed with PCOS do not develop ovarian cysts. The updated terminology aims to encourage a more comprehensive understanding of the condition and the importance of early diagnosis and management.
More Than a Reproductive Condition
PMOS is closely associated with insulin resistance, a condition that can increase the likelihood of developing obesity, prediabetes, type 2 diabetes, and cardiovascular disease.
Among Filipino women living with the condition, obesity remains a significant concern. Recent research found that more than half (52.06%) are classified as obese, while two-thirds reported weight gain as one of their primary symptoms.
Medical experts emphasize that PMOS is not a new disease but rather a more accurate description of an existing condition that affects multiple body systems.
Common symptoms may include:
- Irregular menstrual cycles
- Acne
- Excessive facial or body hair growth
- Hair thinning
- Unexplained weight gain
- Difficulty conceiving
- In some cases, no noticeable symptoms during the early stages
Because symptoms can vary widely, women may not immediately recognize that they are at increased risk for metabolic diseases such as diabetes and heart disease.
Importance of Early Awareness
Healthcare solutions provider Zuellig Pharma is supporting efforts to increase awareness of PMOS as part of broader women’s health initiatives.
The company encourages women to pay closer attention to changes in their menstrual cycle, body weight, and skin health, and to seek medical evaluation if they notice persistent symptoms. Early screening for PMOS, obesity, and diabetes can help patients receive appropriate treatment sooner while reducing the long-term health and financial burden associated with chronic diseases.
Five Signs That May Indicate PMOS
Women are encouraged to consult a healthcare professional if they experience any of the following:
1. Irregular menstrual periods
Menstrual cycles that are absent, infrequent, unusually frequent, unpredictable, or excessively heavy may be an early indicator.
2. Elevated blood sugar or diabetes
Women with abnormal blood glucose levels or those already diagnosed with type 1 or type 2 diabetes may face increased metabolic risks associated with PMOS.
3. Excessive hair growth
Noticeable hair growth on the face, chest, abdomen, or upper thighs may result from hormonal imbalance.
4. Persistent or severe acne
Acne that continues beyond adolescence or does not respond to conventional treatments may be another symptom.
5. Sleep-related concerns
Frequent snoring, poor-quality sleep, excessive daytime fatigue, or waking up feeling unrested may also be linked to the condition.
Early Diagnosis Can Improve Long-Term Health
Medical experts emphasize that PMOS can be effectively managed with timely diagnosis, appropriate treatment, and lifestyle changes. Women experiencing symptoms are advised to consult their healthcare provider for a comprehensive evaluation.
By recognizing PMOS as a condition that affects both reproductive and metabolic health, healthcare professionals hope more women will seek early intervention, reducing their risk of developing diabetes, cardiovascular disease, and other long-term complications.